Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies

David Rosen will present, “Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies” at the ACI 7th National Forum on Off-Label Communications, July 14-15, 2010 at the Union League, in Philadelphia.

Speakers will cover compliance strategies with FDA off-label promotion guidelines, training physicians on the use of medical devices, and learning from device manufacturers’ litigation. Thomas Lynch, Senior Corporate Counsel at Boston Scientific will join Mr. Rosen as a speaker.

More information can be found on ACI’s Web site.